Tech Company Financing Transactions
Haga Bioscience Funding Round
On 6/3/2026, Haga Bioscience raised $2.3 million in Seed funding from Almi Invest, Life Science Angels and private investors.
Transaction Overview
Company Name
Announced On
6/3/2026
Transaction Type
Venture Equity
Amount
$2,300,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to further enhance its product development, commercialization, and collaborations with academic and industry partners to advance translational spatial biology.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Nobels väg 16
Solna, 171 65
Sweden
Solna, 171 65
Sweden
Phone
Undisclosed
Website
Email Address
Overview
Our Mission: Bridging discovery and translation; Spatial omics technologies have transformed how we study tissue biology. However, translating these discoveries into robust, actionable biomarkers remains a major bottleneck, limited by a lack of scalable, cost-effective validation methods. At HAGA.BIO, we believe progress depends on focusing where it truly matters: validating candidate biomarkers directly in real tissue, with precision and scalability.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hower Lee
Chief Marketing Officer
Morgane Rouault
Chief Scientific Officer
Marco Grillo
Chief Technical Officer
Daniel Gyllborg
Browse more venture capital transactions:
Prev: 6/3/2026: WasabiCard venture capital transaction
Next: 6/3/2026: Perk venture capital transaction
Share this article
Where The Data Comes From
We document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs